IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 48 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | -20.0% | 32,692 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $15,000 | -6.2% | 32,692 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $16,000 | -15.8% | 32,692 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $19,000 | -44.1% | 32,692 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $34,000 | -17.1% | 32,692 | -3.5% | 0.00% | -50.0% |
| Q2 2021 | $41,000 | -6.8% | 33,892 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $44,000 | -59.6% | 33,892 | +14.6% | 0.00% | -60.0% |
| Q4 2020 | $109,000 | +94.6% | 29,586 | +13.2% | 0.01% | +66.7% |
| Q3 2020 | $56,000 | +36.6% | 26,140 | +15.2% | 0.00% | +50.0% |
| Q2 2020 | $41,000 | +105.0% | 22,688 | +47.8% | 0.00% | +100.0% |
| Q1 2020 | $20,000 | – | 15,349 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |